Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway

Notoginsenoside R1 (R1), a major component isolated from P. notoginseng, is a phytoestrogen that exerts many neuroprotective effects in a rat model of ischemic stroke. However, its long-term effects on neurogenesis and neurological restoration after ischemic stroke have not been investigated. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ting, Wang, Lei, Xie, Weijie, Meng, Xiangbao, Feng, Yicheng, Sun, Guibo, Sun, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138209/
https://www.ncbi.nlm.nih.gov/pubmed/34025400
http://dx.doi.org/10.3389/fphar.2021.615998
_version_ 1783695762949931008
author Zhu, Ting
Wang, Lei
Xie, Weijie
Meng, Xiangbao
Feng, Yicheng
Sun, Guibo
Sun, Xiaobo
author_facet Zhu, Ting
Wang, Lei
Xie, Weijie
Meng, Xiangbao
Feng, Yicheng
Sun, Guibo
Sun, Xiaobo
author_sort Zhu, Ting
collection PubMed
description Notoginsenoside R1 (R1), a major component isolated from P. notoginseng, is a phytoestrogen that exerts many neuroprotective effects in a rat model of ischemic stroke. However, its long-term effects on neurogenesis and neurological restoration after ischemic stroke have not been investigated. The aim of this study was to evaluate the effects of R1 on neurogenesis and long-term functional recovery after ischemic stroke. We used male Sprague-Dawley rats subjected to middle cerebral artery occlusion/reperfusion (MCAO/R). R1 was administered by intraperitoneal (i.p.) injection immediately postischemia. We showed that R1 significantly decreased infarct volume and neuronal loss, restored neurological function, and stimulated neurogenesis and oligodendrogenesis in rats subjected to MCAO/R. More importantly, R1 promoted neuronal proliferation in PC12 cells in vitro. The proneurogenic effects of R1 were associated with the activation of Akt/cAMP responsive element-binding protein, as shown by the R1-induced increase in brain-derived neurotrophic factor (BDNF) expression, and with the activation of neurological function, which was partially eliminated by selective inhibitors of BDNF and PI3K. We demonstrated that R1 is a promising compound that exerts neuroprotective and proneurogenic effects, possibly via the activation of BDNF/Akt/CREB signaling. These findings offer insight into exploring new mechanisms in long-term functional recovery after R1 treatment of ischemic stroke.
format Online
Article
Text
id pubmed-8138209
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81382092021-05-22 Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway Zhu, Ting Wang, Lei Xie, Weijie Meng, Xiangbao Feng, Yicheng Sun, Guibo Sun, Xiaobo Front Pharmacol Pharmacology Notoginsenoside R1 (R1), a major component isolated from P. notoginseng, is a phytoestrogen that exerts many neuroprotective effects in a rat model of ischemic stroke. However, its long-term effects on neurogenesis and neurological restoration after ischemic stroke have not been investigated. The aim of this study was to evaluate the effects of R1 on neurogenesis and long-term functional recovery after ischemic stroke. We used male Sprague-Dawley rats subjected to middle cerebral artery occlusion/reperfusion (MCAO/R). R1 was administered by intraperitoneal (i.p.) injection immediately postischemia. We showed that R1 significantly decreased infarct volume and neuronal loss, restored neurological function, and stimulated neurogenesis and oligodendrogenesis in rats subjected to MCAO/R. More importantly, R1 promoted neuronal proliferation in PC12 cells in vitro. The proneurogenic effects of R1 were associated with the activation of Akt/cAMP responsive element-binding protein, as shown by the R1-induced increase in brain-derived neurotrophic factor (BDNF) expression, and with the activation of neurological function, which was partially eliminated by selective inhibitors of BDNF and PI3K. We demonstrated that R1 is a promising compound that exerts neuroprotective and proneurogenic effects, possibly via the activation of BDNF/Akt/CREB signaling. These findings offer insight into exploring new mechanisms in long-term functional recovery after R1 treatment of ischemic stroke. Frontiers Media S.A. 2021-05-07 /pmc/articles/PMC8138209/ /pubmed/34025400 http://dx.doi.org/10.3389/fphar.2021.615998 Text en Copyright © 2021 Zhu, Wang, Xie, Meng, Feng, Sun and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhu, Ting
Wang, Lei
Xie, Weijie
Meng, Xiangbao
Feng, Yicheng
Sun, Guibo
Sun, Xiaobo
Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway
title Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway
title_full Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway
title_fullStr Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway
title_full_unstemmed Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway
title_short Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway
title_sort notoginsenoside r1 improves cerebral ischemia/reperfusion injury by promoting neurogenesis via the bdnf/akt/creb pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138209/
https://www.ncbi.nlm.nih.gov/pubmed/34025400
http://dx.doi.org/10.3389/fphar.2021.615998
work_keys_str_mv AT zhuting notoginsenosider1improvescerebralischemiareperfusioninjurybypromotingneurogenesisviathebdnfaktcrebpathway
AT wanglei notoginsenosider1improvescerebralischemiareperfusioninjurybypromotingneurogenesisviathebdnfaktcrebpathway
AT xieweijie notoginsenosider1improvescerebralischemiareperfusioninjurybypromotingneurogenesisviathebdnfaktcrebpathway
AT mengxiangbao notoginsenosider1improvescerebralischemiareperfusioninjurybypromotingneurogenesisviathebdnfaktcrebpathway
AT fengyicheng notoginsenosider1improvescerebralischemiareperfusioninjurybypromotingneurogenesisviathebdnfaktcrebpathway
AT sunguibo notoginsenosider1improvescerebralischemiareperfusioninjurybypromotingneurogenesisviathebdnfaktcrebpathway
AT sunxiaobo notoginsenosider1improvescerebralischemiareperfusioninjurybypromotingneurogenesisviathebdnfaktcrebpathway